Product Program year 2025 Source: CMS Open Payments

Phyrago

Drug Oncology

Open in the dashboard

General payments

$20,807

225 payments

Research payments

$0

0 payments

Through program year 2025, $20,807 in general payments and $0 in research payments were reported against Phyrago (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $20,807 225

Breakdown

Who paid General payments · program year 2025
  1. Cycle Pharmaceuticals Inc $20,807 225 payments
Top recipients General payments · program year 2025
  1. Hagop Kantarjian Medical Oncology · Houston, TX $3,500 17% · 1 payment
  2. Javier Pinilla-Ibarz Hematology · Tampa, FL $2,014 10% · 2 payments
  3. Jorge Cortes-Franco Hematology & Oncology · Houston, TX $1,900 9% · 1 payment
  4. Shira Dinner Hematology & Oncology · Chicago, IL $1,900 9% · 1 payment
  5. Anand Patel Hematology & Oncology · Chicago, IL $1,700 8% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Hematology & Oncology Internal Medicine $12,034 58% · 79 practitioners
  2. Medical Oncology Internal Medicine $3,742 18% · 13 practitioners
  3. Hematology Internal Medicine $2,120 10% · 5 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $760 4% · 32 practitioners
  5. Nurse Practitioner $525 3% · 19 practitioners

The top 5 of 26 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $5,597 27% · 14 recipients
  2. Georgia $4,382 21% · 25 recipients
  3. Illinois $3,667 18% · 5 recipients
  4. California $1,946 9% · 11 recipients
  5. Maryland $1,639 8% · 5 recipients

The top 5 of 34 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

225 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record